United States Self-administered Drugs Market Report 2017

Name: United States Self-administered Drugs Market Report 2017
Brand: QYResearch
SKU: UA2B93D7473EN
Price: 3800 USD
Availability: InStock

December 2017 | 98 pages | ID: UA2B93D7473EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Self-administered Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Self-administered Drugs in these regions, from 2012 to 2022 (forecast).

United States Self-administered Drugs market competition by top manufacturers/players, with Self-administered Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Abbott Laboratories
Bristol-Myers Squibb
Novartis AG
Eli Lilly and Company
Gilead Sciences
Antares Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Injectable Drugs
Inhaled Drugs
Transdermal Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Cardiovascular Diseases
Diabetes
Osteoporosis
Pain Management
Hormone Replacement
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Self-administered Drugs Market Report 2017

1 SELF-ADMINISTERED DRUGS OVERVIEW

1.1 Product Overview and Scope of Self-administered Drugs
1.2 Classification of Self-administered Drugs by Product Category
  1.2.1 United States Self-administered Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Self-administered Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Injectable Drugs
  1.2.4 Inhaled Drugs
  1.2.5 Transdermal Drugs
1.3 United States Self-administered Drugs Market by Application/End Users
  1.3.1 United States Self-administered Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cardiovascular Diseases
  1.3.3 Diabetes
  1.3.4 Osteoporosis
  1.3.5 Pain Management
  1.3.6 Hormone Replacement
  1.3.7 Others
1.4 United States Self-administered Drugs Market by Region
  1.4.1 United States Self-administered Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Self-administered Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Self-administered Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Self-administered Drugs Status and Prospect (2012-2022)
  1.4.5 New England Self-administered Drugs Status and Prospect (2012-2022)
  1.4.6 The South Self-administered Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Self-administered Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Self-administered Drugs (2012-2022)
  1.5.1 United States Self-administered Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Self-administered Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES SELF-ADMINISTERED DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Self-administered Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Self-administered Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Self-administered Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Self-administered Drugs Market Competitive Situation and Trends
  2.4.1 United States Self-administered Drugs Market Concentration Rate
  2.4.2 United States Self-administered Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Self-administered Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SELF-ADMINISTERED DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Self-administered Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Self-administered Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Self-administered Drugs Price by Region (2012-2017)

4 UNITED STATES SELF-ADMINISTERED DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Self-administered Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Self-administered Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Self-administered Drugs Price by Type (2012-2017)
4.4 United States Self-administered Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SELF-ADMINISTERED DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Self-administered Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Self-administered Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SELF-ADMINISTERED DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Abbott Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Self-administered Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Laboratories Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb
  6.2.2 Self-administered Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis AG
  6.3.2 Self-administered Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis AG Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly and Company
  6.4.2 Self-administered Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly and Company Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Gilead Sciences
  6.5.2 Self-administered Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Gilead Sciences Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Antares Pharma
  6.6.2 Self-administered Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Antares Pharma Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 SELF-ADMINISTERED DRUGS MANUFACTURING COST ANALYSIS

7.1 Self-administered Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Self-administered Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Self-administered Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Self-administered Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SELF-ADMINISTERED DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Self-administered Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Self-administered Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Self-administered Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Self-administered Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Self-administered Drugs
Figure United States Self-administered Drugs Market Size (K MT) by Type (2012-2022)
Figure United States Self-administered Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Injectable Drugs Product Picture
Figure Inhaled Drugs Product Picture
Figure Transdermal Drugs Product Picture
Figure United States Self-administered Drugs Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Self-administered Drugs by Application in 2016
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Osteoporosis Examples
Table Key Downstream Customer in Osteoporosis
Figure Pain Management Examples
Table Key Downstream Customer in Pain Management
Figure Hormone Replacement Examples
Table Key Downstream Customer in Hormone Replacement
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Self-administered Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Self-administered Drugs Sales (K MT) and Growth Rate (2012-2022)
Figure United States Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Self-administered Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Self-administered Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Self-administered Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Self-administered Drugs Sales Share by Players/Suppliers
Figure 2017 United States Self-administered Drugs Sales Share by Players/Suppliers
Figure United States Self-administered Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Self-administered Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Self-administered Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Self-administered Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Self-administered Drugs Revenue Share by Players/Suppliers
Table United States Market Self-administered Drugs Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Self-administered Drugs Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Self-administered Drugs Market Share of Top 3 Players/Suppliers
Figure United States Self-administered Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Self-administered Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Self-administered Drugs Product Category
Table United States Self-administered Drugs Sales (K MT) by Region (2012-2017)
Table United States Self-administered Drugs Sales Share by Region (2012-2017)
Figure United States Self-administered Drugs Sales Share by Region (2012-2017)
Figure United States Self-administered Drugs Sales Market Share by Region in 2016
Table United States Self-administered Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Self-administered Drugs Revenue Share by Region (2012-2017)
Figure United States Self-administered Drugs Revenue Market Share by Region (2012-2017)
Figure United States Self-administered Drugs Revenue Market Share by Region in 2016
Table United States Self-administered Drugs Price (USD/MT) by Region (2012-2017)
Table United States Self-administered Drugs Sales (K MT) by Type (2012-2017)
Table United States Self-administered Drugs Sales Share by Type (2012-2017)
Figure United States Self-administered Drugs Sales Share by Type (2012-2017)
Figure United States Self-administered Drugs Sales Market Share by Type in 2016
Table United States Self-administered Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Self-administered Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Self-administered Drugs by Type (2012-2017)
Figure Revenue Market Share of Self-administered Drugs by Type in 2016
Table United States Self-administered Drugs Price (USD/MT) by Types (2012-2017)
Figure United States Self-administered Drugs Sales Growth Rate by Type (2012-2017)
Table United States Self-administered Drugs Sales (K MT) by Application (2012-2017)
Table United States Self-administered Drugs Sales Market Share by Application (2012-2017)
Figure United States Self-administered Drugs Sales Market Share by Application (2012-2017)
Figure United States Self-administered Drugs Sales Market Share by Application in 2016
Table United States Self-administered Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Self-administered Drugs Sales Growth Rate by Application (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Abbott Laboratories Self-administered Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Self-administered Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Self-administered Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Self-administered Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Self-administered Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Self-administered Drugs Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Self-administered Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Self-administered Drugs Sales Market Share in United States (2012-2017)
Figure Novartis AG Self-administered Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Self-administered Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Self-administered Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Self-administered Drugs Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gilead Sciences Self-administered Drugs Sales Growth Rate (2012-2017)
Figure Gilead Sciences Self-administered Drugs Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Self-administered Drugs Revenue Market Share in United States (2012-2017)
Table Antares Pharma Basic Information List
Table Antares Pharma Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Antares Pharma Self-administered Drugs Sales Growth Rate (2012-2017)
Figure Antares Pharma Self-administered Drugs Sales Market Share in United States (2012-2017)
Figure Antares Pharma Self-administered Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Self-administered Drugs
Figure Manufacturing Process Analysis of Self-administered Drugs
Figure Self-administered Drugs Industrial Chain Analysis
Table Raw Materials Sources of Self-administered Drugs Major Players/Suppliers in 2016
Table Major Buyers of Self-administered Drugs
Table Distributors/Traders List
Figure United States Self-administered Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Self-administered Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Self-administered Drugs Price (USD/MT) Trend Forecast (2017-2022)
Table United States Self-administered Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Self-administered Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Self-administered Drugs Sales Volume (K MT) Forecast by Type in 2022
Table United States Self-administered Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Self-administered Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Self-administered Drugs Sales Volume (K MT) Forecast by Application in 2022
Table United States Self-administered Drugs Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Self-administered Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Self-administered Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Self-administered Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Self-administered Drugs Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports